RE: BIG LESSON HERE GUYS.12 May 2025 10:32
Maverick - Positive sentiments but I would be looking for decimals not single digits - if what the respected industry reporters are muting, then there is No reason that this will be the most sought after pharma share to own. They have a product which no other company is anywhere near replicating - otherwise that would have been put to press as a pre-emptive deflection, however a unlike other pharmas this is not only getting industry turning heads but also a seed change in background investment, no vehicle in their right mind is going to stop a revolutionary product getting to market - as some seem to elude to - on the contrary, they will ensure maximum financial return on their investments.
the benefits both medical and financial, in my view, are clear to see.
GLA - OSD